Literature DB >> 30801207

Evaluation of an osteochondral fragment-groove procedure for induction of metacarpophalangeal joint osteoarthritis in horses.

Sarah Y Broeckx, Frederik Pille, Simon Buntinx, Leen Van Brantegem, Luc Duchateau, Maarten Oosterlinck, Koen Chiers, Alicia L Bertone, Jan H Spaas, Ann M Martens.   

Abstract

OBJECTIVE To evaluate lameness and morphological changes associated with an osteochondral fragment-groove procedure as a means of experimental induction of metacarpophalangeal (MCP) joint osteoarthritis within an 11-week period in horses. ANIMALS 6 nonlame adult warmbloods. PROCEDURES The right MCP joint of each horse underwent an osteochondral fragment-groove procedure (day 0). After 1 week of stall rest (ie, starting day 7), each horse was trained daily on a treadmill. Weekly, horses underwent visual and inertial sensor-based assessments of lameness. Both MCP joints were assessed radiographically on days 0 (before surgery), 1, 35, and 77. A synovial fluid sample was collected from the right MCP joint on days 0 (before surgery), 35, 36, 49, 63, and 77 for cytologic and biomarker analyses. On day 77, each horse was euthanized; both MCP joints were evaluated macroscopically and histologically. RESULTS Right forelimb lameness was detected visually and by the inertial sensor system when horses were moving on a straight line after distal forelimb flexion or circling left on days 14 to 77. Compared with presurgical values, synovial fluid interleukin-6, prostaglandin E2, hyaluronic acid, and interleukin-1 receptor antagonist protein concentrations were increased at 2 or 3 time points, whereas tumor necrosis factor-α and interleukin-10 concentrations were decreased at 1 time point. Gross examination of all right MCP joints revealed synovitis and wear lines; synovitis was confirmed histologically. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that a combined osteochondral fragment-groove procedure can be used to induce clinically and grossly observable early MCP joint osteoarthritis during an 11-week period in horses.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30801207     DOI: 10.2460/ajvr.80.3.246

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Effects of oral treatment with chondroitin sulfate and glucosamine in an experimental model of metacarpophalangeal osteoarthritis in horses.

Authors:  Ana Lucia Miluzzi Yamada; Cynthia do Prado Vendruscolo; Marília Ferrari Marsiglia; Eric Danilo Pauls Sotelo; Fernanda Rodrigues Agreste; Sarah Raphaela Torquato Seidel; Joice Fülber; Raquel Yvonne Arantes Baccarin; Luis Claudio Lopes Correia da Silva
Journal:  BMC Vet Res       Date:  2022-06-09       Impact factor: 2.792

2.  The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study.

Authors:  S Y Broeckx; A M Martens; A L Bertone; L Van Brantegem; L Duchateau; L Van Hecke; M Dumoulin; M Oosterlinck; K Chiers; H Hussein; F Pille; J H Spaas
Journal:  Equine Vet J       Date:  2019-04-13       Impact factor: 2.888

Review 3.  Peripheral mechanisms of arthritic pain: A proposal to leverage large animals for in vitro studies.

Authors:  Sampurna Chakrabarti; Minji Ai; Frances M D Henson; Ewan St John Smith
Journal:  Neurobiol Pain       Date:  2020-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.